Increased expression of HMGA1 correlates with tumour invasiveness and proliferation in human pituitary adenomas

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Histopathology

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2559.2010.03495.xPMID 20459557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correction to: Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas

  2022cited by this paper
• Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas

  2009cited by this paper
• High mobility group AT‐hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma

  2008cited by this paper
• HMGA1 controls transcription of insulin receptor to regulate cyclin D1 translation in pancreatic cancer cells.

  2007cited by this paper
• Altered cyclin D1 genotype distribution in human sporadic pituitary adenomas.

  2007cited by this paper
• Roles of HMGA proteins in cancer

  2007influential reference
• Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line.

  2007cited by this paper
• HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma.

  2006cited by this paper
• Increased expression of high mobility group A proteins in lung cancer

  2006cited by this paper
• Mechanisms of Disease: the pathogenesis of pituitary tumors

  2006cited by this paper
• Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas

  2005cited by this paper
• Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas

  2005cited by this paper
• Determination of High Mobility Group A1 (HMGA1) Expression in Hepatocellular Carcinoma: A Potential Prognostic Marker

  2005cited by this paper
• Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models

  2004cited by this paper
• Molecular Pathology Shows p16 Methylation in Nonadenomatous Pituitaries from Patients with Cushing’s Disease

  2004cited by this paper
• Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.

  2004cited by this paper
• High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms

  2003cited by this paper
• HMGI(Y) gene expression in colorectal cancer: comparison with some histological typing, grading, and clinical staging.

  2003cited by this paper
• Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas

  2002cited by this paper
• The pathogenesis of pituitary tumours

  2002cited by this paper
• Role of E-Cadherin, α-, β-, and γ-Catenins, and p120 (Cell Adhesion Molecules) in Prolactinoma Behavior

  2002cited by this paper
• Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior.

  2002cited by this paper
• Coordination of a transcriptional switch by HMGI(Y) acetylation.

  2001cited by this paper
• Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias.

  2000cited by this paper
• Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.

  2000cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Role of Matrix Metalloproteinase 9 in Pituitary Tumor Behavior

  2000cited by this paper
• Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors.

  1999cited by this paper
• Expression of the HMGI(Y) gene in human colorectal cancer

  1999cited by this paper
• Retinoid-dependent Recruitment of a Histone H1 Displacement Activity by Retinoic Acid Receptor*

  1999cited by this paper
• Enhancement of Serum-response Factor-dependent Transcription and DNA Binding by the Architectural Transcription Factor HMG-I(Y)*

  1998cited by this paper
• High level expression of the HMGI (Y) gene during embryonic development.

  1996cited by this paper
• The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias.

  1995cited by this paper
• SARs are cis DNA elements of chromosome dynamics: synthesis of a SAR repressor protein.

  1995cited by this paper
• Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C

  1995cited by this paper
• Metaphase chromosome structure: bands arise from a differential folding path of the highly AT-rich scaffold.

  1994cited by this paper
• Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements.

  1993cited by this paper
• The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure.

  1990cited by this paper
• Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures.

  1989cited by this paper
• Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas

  1987cited by this paper
• Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus.

  1985cited by this paper

• Genetic Basis of ACTH-Secreting Adenomas

  2022cites this paper
• Plurihormonal Pit-1 Positive Pituitary Adenomas: a systematic review and single center series.

  2021cites this paper
• Genetic and Epigenetic Causes of Pituitary Adenomas

  2021cites this paper
• Matrix Metalloproteinase 9 for Evaluating Invasiveness and Recurrence in Pituitary Adenoma Patients: A Meta-analysis

  2020cites this paper
• Differential Expression of HMGA1 and HMGA2 in pituitary neuroendocrine tumors.

  2019cites this paper
• Emerging Role of USP8, HMGA, and Non-Coding RNAs in Pituitary Tumorigenesis

  2019cites this paper
• HMGA1 in cancer: Cancer classification by location

  2019cites this paper
• Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer

  2018cites this paper
• HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer

  2018cites this paper
• Expression of EZH2 in uveal melanomas patients and associations with prognosis

  2017cites this paper
• Increased β‑catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: An assessment using a tissue microarray-based approach.

  2017cites this paper
• Acromegaly: Underdiagnosed in patients with prolactinoma

  2017cites this paper
• Current biomarkers of invasive sporadic pituitary adenomas.

  2016cites this paper
• Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer

  2015cites this paper
• Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer

  2015cites this paper
• Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.

  2015cites this paper
• Epigenetic Mechanisms Leading to Overexpression of HMGA Proteins in Human Pituitary Adenomas

  2015cites this paper
• Genetically Engineered Mouse Models of Pituitary Tumors

  2014cites this paper
• Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth

  2014influential citation
• Overexpression of High Mobility Group A1 Protein in Human Uveal Melanomas: Implication for Prognosis

  2013cites this paper
• New Insights in the Pathogenesis of Pituitary Tumours

  2013cites this paper
• The Wnt/β‐catenin/T‐cell factor 4 pathway up‐regulates high‐mobility group A1 expression in colon cancer

  2013cites this paper
• A classification tree approach for pituitary adenomas.

  2012cites this paper
• Differential expression of folate receptor alpha in pituitary adenomas and its relationship to tumor behavior.

  2012cites this paper
• PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis.

  2012cites this paper
• Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis

  2012cites this paper
• The Genetics of Pituitary Adenomas

  2012cites this paper
• Doctor of Nursing Practice portfolio of Christine Yedinak

  2011cites this paper